Engineering Bioluminescent Sensors of Cyclic AMP to Study Opioid Signaling by Tesmer, Alexander L et al.
  
The Summer Undergraduate Research Fellowship (SURF) Symposium 
2 August 2018 
Purdue University, West Lafayette, Indiana, USA 
Engineering Bioluminescent Sensors of Cyclic AMP to Study 
Opioid Signaling 
Alexander L. Tesmer, Alexander R. French, and Mathew Tantama 
Department of Science, Purdue University 
ABSTRACT 
Opioids are small signaling molecules which bind to opioid receptors on the surface of cells. The kappa opioid 
receptor (KOR) is one of three major types of opioid receptors found in human neurons. When an opioid binds to 
a KOR, a variety of biochemical signaling pathways are activated inside the cell. Each of these pathways are 
associated with different physiological effects of KOR activation. The production of a small signaling molecule, 
cyclic adenosine monophosphate (cAMP), is known to be inhibited during KOR activation of the analgesic (pain-
killing) signaling pathway. The ability to interrogate the individual responses of KOR signaling pathways in a living 
mammal would greatly improve our understanding of how opioids work in the brain. To this end, we have 
developed a biosensor functioning via bioluminescent resonance energy transfer (BRET) as a tool for both 
fluorescent and luminescent ratiometric quantification of cAMP. We couple two fluorescent proteins, emitting at 
different wavelengths, to a luciferase which provides chemiluminescent excitation energy for the complex. The 
intensity of the two emitted wavelengths vary inversely to each other in response to the presence of cAMP. 
Calculating the ratio of the two emission intensities creates a metric for cAMP concentration that is normalized to 
the concentration of our sensor, allowing quantitative comparison across trials. The application of our sensor for 
dual-color live-cell microscopy was demonstrated in mammalian cells using fluorescence and bioluminescence 
microscopy. Further proof-of-principle studies in KOR-expressing mammalian cells demonstrates the viability of 
our sensor for live-cell KOR signaling. 
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